Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 173
Evidence-Based Medicine and the Changing Nature of Health Care Appendix A Meeting Agenda EVIDENCE-BASED MEDICINE AND THE CHANGING NATURE OF HEALTH CARE THE NATIONAL ACADEMY OF SCIENCES BUILDING 2100 C STREET, N.W. WASHINGTON, D.C. MONDAY, OCTOBER 8 9:20 a.m. INTRODUCTION OF THE PROGRAM Mark B. McClellan, M.D., Ph.D., Senior Fellow and Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health 9:30 a.m. WHAT FORCES ARE DRIVING THE NEED FOR BETTER MEDICAL EVIDENCE? Chair: Denis A. Cortese, M.D., President and Chief Executive Officer, Mayo Clinic Relationship Between Health Care and the Evidence Base: Current Profile Elliott S. Fisher, M.D., M.P.H., Professor of Medicine and Community and Family Medicine, Center for the Evaluative Clinical Sciences, Dartmouth Medical School How the Pace of New Health Product Introduction Affects the Need for Evidence Molly J. Coye, M.D., M.P.H., Founder and Chief Executive Officer, Health Technology Center
OCR for page 174
Evidence-Based Medicine and the Changing Nature of Health Care How the Pace of New Insights into Genetic Variation Affects the Need for Evidence David M. Altshuler, Ph.D., M.D., Director of Medical and Population Genetics, Broad Institute Impact of the Evidence Shortfall on Health Care Costs, Public Budgets, and the Economy Peter R. Orszag, Ph.D., Director, Congressional Budget Office 10:30 a.m. QUESTIONS AND DISCUSSION 10:50 a.m. BREAK 11:10 a.m. HOW CAN PATIENTS AND PROVIDERS CONTEND WITH THE CHANGES? Chair: Michael M. E. Johns, M.D., Chancellor, Emory University Practical Front-Line Challenges and the Future of Expert-Based Care William W. Stead, M.D., McKesson Foundation Professor of Medicine and Biomedical Informatics, and Associate Vice Chancellor for Strategy and Transformation, Vanderbilt University The Patient-Physician Partnership in Fostering an Evidence-Driven Environment Marc Boutin, Esq., Executive Vice President, National Health Council Information Technology Tools That Support Best Practices by Healthcare Providers Robert Hayward, M.D., M.P.H., F.R.C.P.C., Associate Professor, Departments of Medicine and Public Health Sciences, and Director, Centre for Health Evidence, University of Alberta Consumer-Accessible, Web-Based Health Information to Empower Patients Peter M. Neupert, M.B.A., Corporate Vice President, Health Solutions Group, Microsoft Corporation 12:10 p.m. QUESTIONS AND DISCUSSION 12:30 p.m. LUNCH BREAK
OCR for page 175
Evidence-Based Medicine and the Changing Nature of Health Care 2:00 p.m. WHAT’S NEEDED TO TRANSFORM THE SPEED AND RELIABILITY OF NEW EVIDENCE? Chair: John W. Rowe, M.D., Professor, Department of Health Policy and Management, Columbia University Mailman School of Public Health Electronic Health Records and the Prospect of Real-Time Evidence Development George C. Halvorson, Chairman and Chief Executive Officer, Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals Research Methods to Speed the Development of Better Evidence Eric D. Peterson, M.D., M.P.H., Professor of Medicine, Duke Clinical Research Institute Biopharmaceutical and Medical Device Development: Tailored Therapies Meet Evidence-Based Medicine Steven M. Paul, M.D., Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company 2:45 p.m. QUESTIONS AND DISCUSSION 3:00 p.m. HOW CAN POLICY CHANGES IMPROVE THE VALUE WE GET FROM HEALTH CARE? Chair: John K. Iglehart, Founding Editor, Health Affairs, and National Correspondent, New England Journal of Medicine What Is Value in Health Care? Michael E. Porter, Ph.D., Bishop William Lawrence University Professor, Harvard Business School Regulatory and Financing Reforms Necessary for Effective Health Care Donna E. Shalala, Ph.D., President, University of Miami 3:30 p.m. QUESTIONS AND DISCUSSION 4:00 p.m. CLOSING REMARKS Mark B. McClellan, M.D., Ph.D. Elizabeth G. Nabel, M.D.
OCR for page 176
Evidence-Based Medicine and the Changing Nature of Health Care This page intentionally left blank.